Survey Finds People with Cystic Fibrosis Using a CFTR Modulator Have Positive View of Treatment Plans, HCP Relationships, Future

A new survey from Health Union, Cystic Fibrosis In America 2019, finds that people with the condition who currently use a cystic fibrosis transmembrane conductance regulator (CFTR) modulator tend to have a more positive view about their futures, treatment plans and healthcare professional relationships than those who have never used one.
Health Union Named to 2019 Deloitte 500

Health Union Ranked No. 209 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™

Health Union today announced it ranked No. 209 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America, now in its 25th year. Health Union grew 521% from 2015 to 2018.

Atopic Dermatitis In America 2019

Survey Shows People Who First Developed Atopic Dermatitis Symptoms As Kids Experience More Severe Symptoms

A new survey from Health Union, Atopic Dermatitis In America 2019, finds that people who begin experiencing atopic dermatitis symptoms as children have vastly different patient journeys and experiences, from those who began experiencing symptoms as adults. The survey illuminates the perspectives and experiences of people impacted by atopic dermatitis.

Alzheimer's Disease In America 2019

Alzheimer’s Survey Finds Type, Level of Care Provided By Caregivers Significantly Differs Based on Patient’s Stage

A new survey from Health Union finds that the experiences of caregivers of people with Alzheimer’s disease differ greatly as the condition progresses through the three stages. Specifically, those witnessing a severe form of Alzheimer’s are more involved in helping the patient complete day-to-day tasks and having tough conversations, caregivers of moderate-stage patients are acutely focused on managing medical care and caregivers of mild-stage patients are dealing with the stresses of caring for a person who is starting to experience memory lapses.

MS In America 2019

MS Survey Finds Positive HCP Relationships, Proactive Medication Interest Likely Indicators of DMT Use

A new survey from Health Union finds that people with relapsing forms of multiple sclerosis (MS) who currently use a disease-modifying therapy (DMT) report positive relationships with their healthcare professionals (HCP) and interest in prescription therapies, while those who have never used a DMT prefer alternative therapies and have experienced a less straight-forward MS journey than their counterparts.